Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
Dalton Transactions (Cambridge, England : 2003)
|
May 24, 2016
Platinum(iv) anticancer prodrugs - hypotheses and facts
Dan Gibson
Journal of Inorganic Biochemistry
|
November 25, 2018
Multi-action Pt(IV) anticancer agents; do we understand how they work?
Dan Gibson
Dalton Transactions (Cambridge, England : 2003)
|
December 22, 2009
The mechanism of action of platinum anticancer agents--what do we really know about it?
Dan Gibson
Chemmedchem
|
April 30, 2021
Pt(IV) Anticancer Prodrugs - A Tale of Mice and Men
Dan Gibson
Journal of Inorganic Biochemistry
|
January 21, 2021
Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
Dan Gibson
Journal of Inorganic Biochemistry
|
August 11, 2012
What do we know about the reduction of Pt(IV) pro-drugs?
Ezequiel Wexselblatt, Dan Gibson
Rapid Communications in Mass Spectrometry : RCM
|
November 15, 2005
Mass spectrometric studies of the formation and reactivity of trans-[PtCl2(Am)(piperidinopiperidine)] x HCl complexes with ubiquitin
Liliana Balter, Dan Gibson
Journal of Medicinal Chemistry
|
June 23, 2009
Is glutathione the major cellular target of cisplatin? A study of the interactions of cisplatin with cancer cell extracts
Yonit Kasherman, Stefan Sturup, Dan Gibson
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
December 5, 2008
Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts
Yonit Kasherman, Stefan Sturup, Dan Gibson
Angewandte Chemie (International Ed. in English)
|
May 21, 2013
Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions
Ezequiel Wexselblatt, Eylon Yavin, Dan Gibson
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
Dalton Transactions (Cambridge, England : 2003)
|
May 24, 2016
Platinum(iv) anticancer prodrugs - hypotheses and facts
Dan Gibson
Journal of Inorganic Biochemistry
|
November 25, 2018
Multi-action Pt(IV) anticancer agents; do we understand how they work?
Dan Gibson
Dalton Transactions (Cambridge, England : 2003)
|
December 22, 2009
The mechanism of action of platinum anticancer agents--what do we really know about it?
Dan Gibson
Chemmedchem
|
April 30, 2021
Pt(IV) Anticancer Prodrugs - A Tale of Mice and Men
Dan Gibson
Journal of Inorganic Biochemistry
|
January 21, 2021
Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
Dan Gibson
Journal of Inorganic Biochemistry
|
August 11, 2012
What do we know about the reduction of Pt(IV) pro-drugs?
Ezequiel Wexselblatt, Dan Gibson
Rapid Communications in Mass Spectrometry : RCM
|
November 15, 2005
Mass spectrometric studies of the formation and reactivity of trans-[PtCl2(Am)(piperidinopiperidine)] x HCl complexes with ubiquitin
Liliana Balter, Dan Gibson
Journal of Medicinal Chemistry
|
June 23, 2009
Is glutathione the major cellular target of cisplatin? A study of the interactions of cisplatin with cancer cell extracts
Yonit Kasherman, Stefan Sturup, Dan Gibson
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry
|
December 5, 2008
Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts
Yonit Kasherman, Stefan Sturup, Dan Gibson
Angewandte Chemie (International Ed. in English)
|
May 21, 2013
Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions
Ezequiel Wexselblatt, Eylon Yavin, Dan Gibson
Page
of 9